Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8442430 | European Journal of Cancer | 2015 | 8 Pages |
Abstract
Within a large EOC-patient cohort with 1st-line platinum- and taxane-based chemotherapy early onset alopecia appears to be significantly associated with a more favourable outcome in those patients who completed ⩾6 chemotherapy cycles. It remains to be elucidated if early onset alopecia is just a surrogate marker for higher sensitivity to chemotherapy or if other biological effects are underlying.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jalid Sehouli, Christina Fotopoulou, Edibe Erol, Rolf Richter, Alexander Reuss, Sven Mahner, Eric Pujade Lauraine, Gunnar Kristensen, Jörn Herrstedt, Andreas du Bois, Jacobus Pfisterer,